- cross-posted to:
- news@hexbear.net
- cross-posted to:
- news@hexbear.net
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
Confessions by proxy according to the article and cleared by DNA. I don’t see the relevance?
No relevance, sorry. It was interesting. Just goes to show the truthfulness of some testimonies.